2.75
price up icon3.00%   0.08
after-market アフターアワーズ: 2.76 0.010 +0.36%
loading
前日終値:
$2.67
開ける:
$2.68
24時間の取引高:
134.18K
Relative Volume:
1.65
時価総額:
$35.32M
収益:
-
当期純損益:
$-70.20M
株価収益率:
-0.0614
EPS:
-44.82
ネットキャッシュフロー:
$-50.66M
1週間 パフォーマンス:
+8.70%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
-36.05%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$2.63
$2.80
1週間の範囲:
Value
$2.445
$2.85
52週間の値動き範囲:
Value
$1.70
$19.40

Onkure Therapeutics Inc Stock (OKUR) Company Profile

Name
名前
Onkure Therapeutics Inc
Name
セクター
Healthcare (1147)
Name
電話
(720) 307-2892
Name
住所
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Name
職員
46
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
OKUR's Discussions on Twitter

OKUR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
OKUR
Onkure Therapeutics Inc
2.75 36.12M 0 -70.20M -50.66M -44.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-30 開始されました Evercore ISI Outperform
2024-12-05 開始されました Leerink Partners Outperform
2024-10-10 開始されました Oppenheimer Outperform
2023-12-15 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-15 ダウングレード Jefferies Buy → Hold
2023-12-15 ダウングレード Leerink Partners Outperform → Market Perform
2023-12-14 ダウングレード BofA Securities Buy → Underperform
2023-12-14 ダウングレード Ladenburg Thalmann Buy → Neutral
2023-12-14 ダウングレード Piper Sandler Overweight → Neutral
2023-12-14 ダウングレード Robert W. Baird Outperform → Neutral
2023-12-14 ダウングレード William Blair Outperform → Mkt Perform
2023-11-15 開始されました William Blair Outperform
2023-08-28 開始されました H.C. Wainwright Buy
2023-07-03 開始されました BofA Securities Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-01-27 開始されました Robert W. Baird Outperform
2021-12-21 開始されました H.C. Wainwright Buy
2021-11-22 開始されました Ladenburg Thalmann Buy
2021-05-04 開始されました Jefferies Buy
2021-05-04 開始されました Piper Sandler Overweight
2021-05-04 開始されました SVB Leerink Outperform
すべてを表示

Onkure Therapeutics Inc (OKUR) 最新ニュース

pulisher
Sep 30, 2025

Relative strength of OnKure Therapeutics Inc. in sector analysisMarket Movers & Advanced Swing Trade Entry Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What data driven models say about OnKure Therapeutics Inc.’s futureMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Using Python tools to backtest OnKure Therapeutics Inc. strategiesJuly 2025 Technicals & Entry Point Strategy Guides - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

OnKure Therapeutics Inc. stock volume spike explainedJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Applying Wyckoff theory to OnKure Therapeutics Inc. stockWeekly Investment Recap & Fast Exit and Entry Strategy Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Can trapped investors hope for a rebound in OnKure Therapeutics Inc.Gap Down & Weekly High Potential Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

How OnKure Therapeutics Inc. stock trades before earningsWeekly Volume Report & Growth Focused Investment Plans - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about OnKure Therapeutics Inc stockTrading Volume Surges & High Return Wealth Plans - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

What drives OnKure Therapeutics Inc stock priceGrowth vs. Value Investing & You’ve Never Seen Stock Picks Like These - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Advanced analytics toolkit walkthrough for OnKure Therapeutics Inc.Portfolio Growth Summary & Stepwise Trade Execution Plans - newser.com

Sep 27, 2025
pulisher
Sep 25, 2025

LifeSci Capital Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Raises Target Price to $21 - 富途牛牛

Sep 25, 2025
pulisher
Sep 25, 2025

OnKure Therapeutics CEO Saccomano sells $230 in stock By Investing.com - Investing.com Australia

Sep 25, 2025
pulisher
Sep 24, 2025

OnKure Therapeutics CEO Saccomano sells $230 in stock - Investing.com India

Sep 24, 2025
pulisher
Sep 24, 2025

OKUR SEC FilingsOnKure Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

Sep 24, 2025
pulisher
Sep 22, 2025

Quantitative breakdown of OnKure Therapeutics Inc. recent movePortfolio Return Summary & AI Powered Trade Plan Recommendations - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Can OnKure Therapeutics Inc. recover in the next quarterJuly 2025 Outlook & Daily Entry Point Alerts - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Backtesting results for OnKure Therapeutics Inc. trading strategiesEarnings Overview Summary & Stock Portfolio Risk Management - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Does OnKure Therapeutics Inc have high return on assets2025 Trading Recap & Risk Controlled Stock Pick Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Published on: 2025-09-20 08:05:52 - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Detecting price anomalies in OnKure Therapeutics Inc. with AIPortfolio Gains Report & Weekly Stock Performance Updates - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

Published on: 2025-09-20 05:11:15 - khodrobank.com

Sep 19, 2025

Onkure Therapeutics Inc (OKUR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
大文字化:     |  ボリューム (24 時間):